Bellevue Life Sciences Ac... (BLAC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
11.40
0.06 (0.53%)
At close: Jan 03, 2025, 9:00 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a |
Operating Income | -1.83M | -35.39K | -3.31K | -23.81K |
Interest Income | n/a | n/a | n/a | n/a |
Pretax Income | 944.59K | -35.39K | -3.31K | -23.81K |
Net Income | 403.78K | -35.39K | -3.31K | -23.81K |
Selling & General & Admin | 1.83M | 35.39K | 3.31K | 23.81K |
Research & Development | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a |
Operating Expenses | 1.83M | 35.39K | 3.31K | 23.81K |
Interest Expense | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.83M | 35.39K | 3.31K | 23.81K |
Income Tax | 540.81K | -228.48K | -236.56K | -206.30K |
Shares Outstanding (Basic) | 5.62M | 9.05M | 7.93M | 7.89M |
Shares Outstanding (Diluted) | 5.62M | 9.05M | 7.93M | 7.89M |
EPS (Basic) | 0.07 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | 0.07 | -0.00 | -0.00 | -0.00 |
EBITDA | 944.59K | -35.39K | -3.31K | -23.81K |
Depreciation & Amortization | 2.78M | 228.49K | 236.56K | 206.30K |